THC Therapeutics Overview

  • Founded
  • 2007
  • Status
  • Public
  • Employees
  • 3
  • Stock Symbol
  • THCT
Stock Symbol
  • Investments
  • 5
  • Share Price
  • $0.04
  • (As of Thursday Closing)

THC Therapeutics General Information


THC Therapeutics Inc is a United States-based company. It is focused on developing dHydronator, a sanitizing herb dryer. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis. It will reduce the drying time for cannabis from 10-14 days down to less than 14 hours while reducing the viability of microbial contaminants.

Contact Information

Formerly Known As
Harmonic Energy, Aviation Surveillance Systems
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Holding Companies
Other Industries
Other Financial Services
Stock Exchange
Primary Office
  • 11700 West Charleston Boulevard
  • Suite 73
  • Las Vegas, NV 89135
  • United States
+1 (702) 000-0000

THC Therapeutics Timeline

Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

THC Therapeutics Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.04 $0.03 $0.03 - $1.75 $751K 21.5M 32.5K $0.11

THC Therapeutics Financials Summary

In Thousands,
TTM 30-Apr-2020 FY 2019 31-Jul-2019 FY 2018 31-Jul-2018 FY 2017 31-Jul-2017
EV 1,757 36,400 34,860 37,449
Revenue 0 0 0 0
EBITDA 989 (22,978) (6,012) 185
Net Income 534 (23,307) (6,139) 10
Total Assets 232 520 2,520 194
Total Debt 406 178 176 83
Public Fundamental Data provided by Morningstar, Inc. disclaimer

THC Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore THC Therapeutics‘s full profile, request access.

Request a free trial

THC Therapeutics Executive Team (2)

Name Title Board Seat Contact Info
Brandon Romanek Chief Executive Officer & Chief Financial Officer, Finance
Joshua Halford Executive, Business Development
To view THC Therapeutics’s complete executive team members history, request access »

THC Therapeutics Board Members (1)

Name Representing Role Since
0000 0000000 Self Board Member 000 0000
To view THC Therapeutics’s complete board members history, request access »

THC Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

THC Therapeutics Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000 27-Jun-2018 000000000 00000000 000 Asset Management 0000000 0000000
00000000000 26-Mar-2018 000000000 00000000 000.00 Financial Software 0000000 0000000
0000000 08-Feb-2018 000000000 000 Business/Productivity Software 0000000 0000000
0000 20-Nov-2017 00000 0000000 Media and Information Services (B2B) 0000000 0000000
Harmonic Energy 23-Jan-2017 Merger/Acquisition Other Commercial Services 0000000 0000000
To view THC Therapeutics’s complete investments and acquisitions history, request access »

THC Therapeutics Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 20-Nov-2017 00000 0000000 Completed
  • 2 buyers
To view THC Therapeutics’s complete exits history, request access »